EUVIMEDEUVIMED entdecken
Fallbericht

Functional Characterization of a Novel GPC3 Missense Variant in Simpson–Golabi–Behmel Syndrome

Teresa Zhao iD, Kirsten Allan iD, Juliet Taylor iD, David R Thorburn iD, Susan M White iD, Tiong Y Tan iD, John Christodoulou iD, Natalie B Tan iD, David A Stroud iD

American Journal of Medical Genetics Part A · 2026

DOI: 10.1002/ajmg.a.64287 ↗

Kurz gefasst

Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2026. Verfasst von Teresa Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Glypicans, Mutation, Missense, Gigantism, Genetic Diseases, X-Linked. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: University of Melbourne, Victorian Government's Operational Infrastructure Support Program, Royal Children's Hospital Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Simpson–Golabi–Behmel syndrome 1 (SGBS1) is a rare X‐linked recessive condition characterized by overgrowth and multiple congenital anomalies. SGBS1 is caused by damaging variants in the Glypican‐3 ( GPC3 ) gene. The GPC3 protein plays a crucial role in cellular signaling processes including cell growth, embryogenesis, and differentiation. Functional maturation of GPC3 occurs via several steps of post‐translational modification (PTM) and processing to enable its transport to, and anchorage on, the plasma membrane. GPC3 positively modulates the canonical Wnt signaling pathways, while negatively regulating the Hedgehog signaling pathways. Loss‐of‐function is the underlying mechanism of disease for SGBS1, with a minority of reported pathogenic variants being missense substitutions. We report a family with four affected individuals in whom a novel GPC3 missense variant was identified via exome sequencing: NM_004484.3: c.695C>A; p.(Ala232Asp). The variant segregated with disease in the family, and functional studies conducted using HEK293T cells demonstrate a distinct mis‐localization of the mutant GPC3 protein, thereby supporting the pathogenicity of this novel missense variant. These findings allowed for an upgraded classification of the missense variant from a variant of uncertain significance to that of likely pathogenic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlypicansMutation, MissenseGigantismGenetic Diseases, X-LinkedIntellectual DisabilityHeart Defects, CongenitalArrhythmias, CardiacHumansMalePedigreeFemaleHEK293 CellsExome Sequencing

Stichwörter der Autor:innen

GPC3Simpson–Golabi–Behmel syndrome 1 (SGBS1)missense variantmis‐localization

Substanzen

GlypicansGPC3 protein, human

Autor:innen und Institutionen

  • Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Victoria, Australia.
  • Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.
  • Victorian Clinical Genetics Services, Royal Children's Hospital, Melbourne, Victoria, Australia.
  • Genetic Health Service NZ (Northern Hub), Auckland, New Zealand.
  • Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
  • Department of Biochemistry & Pharmacology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Melbourne, Victoria, Australia.

ORCID-Profile: Teresa Zhao, Kirsten Allan, Juliet Taylor, David R Thorburn, Susan M White, Tiong Y Tan, John Christodoulou, Natalie B Tan, David A Stroud

Förderung

  • University of Melbourne
  • Victorian Government's Operational Infrastructure Support Program
  • Royal Children's Hospital Foundation
  • Murdoch Children's Research Institute
  • The Harbig Foundation
  • Paula Fox
  • The Andrew and Geraldine Buxton Foundation
  • Pierce Armstrong Foundation

Zitieren

APA

Zhao, T., Allan, K., Taylor, J., Thorburn, D. R., White, S. M., Tan, T. Y., Christodoulou, J., Tan, N. B., & Stroud, D. A. (2026). Functional Characterization of a Novel GPC3 Missense Variant in Simpson–Golabi–Behmel Syndrome. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.64287

Vancouver

Zhao T, Allan K, Taylor J, Thorburn DR, White SM, Tan TY, et al. Functional Characterization of a Novel GPC3 Missense Variant in Simpson–Golabi–Behmel Syndrome. American Journal of Medical Genetics Part A. 2026. doi:10.1002/ajmg.a.64287

BibTeX
@article{Zhao2026,
  author = {Zhao, Teresa and Allan, Kirsten and Taylor, Juliet and Thorburn, David R and White, Susan M and Tan, Tiong Y and Christodoulou, John and Tan, Natalie B and Stroud, David A},
  title = {Functional Characterization of a Novel GPC3 Missense Variant in Simpson–Golabi–Behmel Syndrome},
  journal = {American Journal of Medical Genetics Part A},
  year = {2026},
  doi = {10.1002/ajmg.a.64287}
}
Kostenlos starten →